Abacus Gets Purchase Order from Pharmacy Retailers

- April 11th, 2019

Abacus Health Products announced a round of purchase orders from different retailers for its CBDMEDIC line of “topical pain medications.”

Abacus Health Products (CSE:ABCS) announced a round of purchase orders from different retailers for its CBDMEDIC line of “topical pain medications.”

As quoted in the press release:

These new orders from five US retail chains, including CVS Pharmacy, Weis Markets, and Pharmacare Inc., bring CBDMEDIC products to over 1,100 pharmacy and supermarket retail locations throughout the country.

“These new purchase orders demonstrate strong momentum and the successful execution of our retail growth strategy,” said Perry Antelman, CEO of Abacus. “Moving forward, we continue to identify and pursue opportunities to further expand the availability of our range of CBDMEDIC products. We are providing new and innovative products for consumers seeking topical pain relief and therapeutic skincare treatment.”

Click here to read the full press release.

Get the latest Cannabis Investing stock information

Get the latest information about companies associated with Cannabis Investing Delivered directly to your inbox.

Cannabis Investing

Select All
Select None

Tags

Tags:

Leave a Reply

Your email address will not be published. Required fields are marked *